200 related articles for article (PubMed ID: 9741341)
1. Changes in cellular response to mycobacterial antigens and cytokine production patterns in leprosy patients during multiple drug therapy.
Trao VT; Huong PL; Thuan AT; Anh DD; Trach DD; Rook GA; Wright EP
Immunology; 1998 Jun; 94(2):197-206. PubMed ID: 9741341
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
3. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT).
Rada E; Ulrich M; Aranzazu N; Rodriguez V; Centeno M; Gonzalez I; Santaella C; Rodriguez M; Convit J
Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):320-7. PubMed ID: 9401484
[TBL] [Abstract][Full Text] [Related]
4. Immunochemotherapy with interferon-gamma and multidrug therapy for multibacillary leprosy.
Barral-Netto M; Santos S; Santos I; von Sohsten R; Bittencourt AL; Carvalho EM; Barral A; Waters M
Acta Trop; 1999 Mar; 72(2):185-201. PubMed ID: 10206118
[TBL] [Abstract][Full Text] [Related]
5. Host immune responses induced by specific Mycobacterium leprae antigens in an overnight whole-blood assay correlate with the diagnosis of paucibacillary leprosy patients in China.
Chen X; You YG; Yuan YH; Yuan LC; Wen Y
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007318. PubMed ID: 31017900
[TBL] [Abstract][Full Text] [Related]
6. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
8. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
9. Long-term evaluation of immune status in leprosy patients undergoing multiple drug therapy.
Vu TT; Hoang TL; Nguyen DQ; Ho ML; Nguyen DH; Le TH; Dang DT; Nguyen QA; Le TP; Tran HK
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):365-73. PubMed ID: 7963908
[TBL] [Abstract][Full Text] [Related]
10. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae.
Misra N; Murtaza A; Walker B; Narayan NP; Misra RS; Ramesh V; Singh S; Colston MJ; Nath I
Immunology; 1995 Sep; 86(1):97-103. PubMed ID: 7590888
[TBL] [Abstract][Full Text] [Related]
11. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
[TBL] [Abstract][Full Text] [Related]
12. Alterations to antigen-specific immune responses before and after multidrug therapy of leprosy.
Freitas AA; Oliveira RM; Hungria EM; Cardoso LP; Sousa AL; Costa MB; Reed SG; Duthie MS; Stefani MM
Diagn Microbiol Infect Dis; 2015 Oct; 83(2):154-61. PubMed ID: 26233487
[TBL] [Abstract][Full Text] [Related]
13. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.
Upadhyay R; Dua B; Sharma B; Natrajan M; Jain AK; Kithiganahalli Narayanaswamy B; Joshi B
BMC Infect Dis; 2019 Jan; 19(1):52. PubMed ID: 30642265
[TBL] [Abstract][Full Text] [Related]
14. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-12 amplifies the M. leprae hsp65-cytotoxic response in the presence of tumour necrosis factor-alpha and interferon-gamma generating CD56+ effector cells: interleukin-4 downregulates this effect.
Aleman M; De La Barrera S; Fink S; Finiasz M; Farina MH; Pizzariello G; Sasiain MD
Scand J Immunol; 2000 Mar; 51(3):262-70. PubMed ID: 10736095
[TBL] [Abstract][Full Text] [Related]
16. Defective production of monocyte-activating cytokines in lepromatous leprosy.
Horwitz MA; Levis WR; Cohn ZA
J Exp Med; 1984 Mar; 159(3):666-78. PubMed ID: 6366107
[TBL] [Abstract][Full Text] [Related]
17.
Bezerra-Santos M; do Vale-Simon M; Barreto AS; Cazzaniga RA; de Oliveira DT; Barrios MR; Ferreira AR; Santos-Bio NC; Reed SG; de Almeida RP; Corrêa CB; Duthie MS; de Jesus AR
Front Immunol; 2018; 9():2920. PubMed ID: 30631322
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.
Oliveira RM; Hungria EM; de Araújo Freitas A; de Sousa AL; Costa MB; Reed SG; Duthie MS; Stefani MM
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1415-24. PubMed ID: 24619112
[TBL] [Abstract][Full Text] [Related]
19. Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions.
Santos MB; de Oliveira DT; Cazzaniga RA; Varjão CS; Dos Santos PL; Santos MLB; Correia CB; Faria DR; Simon MDV; Silva JS; Dutra WO; Reed SG; Duthie MS; de Almeida RP; de Jesus AR
Scand J Immunol; 2017 Jul; 86(1):40-49. PubMed ID: 28426172
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
